A prospective study on the incidence and influencing factors of type 2 diabetes mellitus in rural population in Xinjiang
-
摘要:
目的 探究新疆维吾尔自治区农村人群2型糖尿病(type 2 diabetes mellitus, T2DM)发病情况及影响因素,对比维吾尔族和哈萨克族人群T2DM影响因素的差异,为该地区人群开展有针对性的T2DM预防措施提供依据。 方法 选择2010年和2016年新疆维吾尔自治区2个具有代表性的地区,对研究对象进行问卷调查、体格检查和血液样本采集。于2013―2017年对哈萨克族进行随访调查,于2019―2022年对维吾尔族进行随访调查,以随访满5年的人群作为研究对象。采用Cox比例风险模型评估影响因素与T2DM事件发病风险之间的关联。 结果 共纳入5 714名研究对象,其中3 304名维吾尔族和2 410名哈萨克族研究对象,随访期间新发T2DM分别为428例和165例,累积发病率分别为13.0%、6.8%;两组人群的常见危险因素包括年龄增长、T2DM家族史、肥胖、高血压、三酰甘油(triglyceride, TG)异常。低密度脂蛋白胆固醇(low density lipoprotein cholesterol, LDL-C)异常和高密度脂蛋白胆固醇(high density lipoprotein cholesterol, HDL-C)异常是维吾尔族人群T2DM特有的危险因素,男性、超重和总胆固醇(total cholesterol, TC)异常是哈萨克族人群T2DM特有的危险因素。 结论 维吾尔族人群T2DM发病率高于哈萨克族,两民族T2DM发病因素及其关联强度均有一定差异,针对不同生活方式和民族特点,应开展相应的T2DM防控措施。 Abstract:Objective This study aims to explore the incidence and influencing factors of type 2 diabetes mellitus (T2DM) among rural populations in Xinjiang, comparing risk factors between the Uyghur and Kazakh ethnic groups and proposing targeted prevention measures. Methods Two representative regions in the Xinjiang were selected for questionnaire surveys, physical exams, and blood sample collection from the study subjects in 2010 and 2016, with follow-up studies from 2013 to 2017 (Kazakh) and 2019 to 2022 (Uyghur), Populations with a follow-up period of at least 5 years were selected as the study subjects. The Cox proportional hazards regression model was employed to assess the relationship between influencing factors and the risk of T2DM. Results The study included a total of 5 714 participants, including 3 304 Uygur ethnic group participants and 2 410 Kazakh ethnic group participants. During the follow-up period, 428 new cases of T2DM were reported in the Uygur group and 165 new cases in the Kazakh group. The cumulative incidence of new-onset T2DM was 13.0% in the Uyghur population, higher than the 6.8% in the Kazakh population. Common risk factors for both groups include older age, family history of T2DM, obesity, hypertension, and abnormal triglycerides (TG). Additional risk factors specific to the Uyghur group are abnormal LDL-C and HDL-C, while those specific to the Kazakh group include male, being overweight, and abnormal total cholesterol (TC). Conclusions T2DM incidence is higher among the Uyghur population than the Kazakh population. There are notable differences in the incidence factors and correlation strengths of T2DM between the two ethnic groups. Given the varying lifestyles and ethnic characteristics, it is essential to implement tailored prevention and control measures for T2DM. -
表 1 新疆维吾尔自治区农村人群基线特征
Table 1. Baseline characteristics of rural populations in Xinjiang
特征
Characteristic维吾尔族Uyghurs①
(n=3 304)哈萨克族Kazak①
(n=2 410)t/χ2值value P值
value年龄/岁 Age/years 40.48±13.22 44.23±14.45 10.17 0.001 男性 Male 1 436(43.5) 985(40.9) 3.832 0.050 文化程度:高中及以上 Education leve: high school l or above 258(7.8) 263(10.9) 1 233.688 0.001 婚姻状况: 已婚 Marital status: married 2 865(86.7) 2 074(86.1) 38.862 0.001 T2DM家族史 Family history of T2DM 241(7.3) 87(3.6) 34.958 0.001 高血压家族史 Family history of high blood pressure 268(6.3) 406(17.0) 101.020 0.001 冠心病家族史 Family history of coronary heart disease 205(6.2) 149(6.2) 0.001 0.973 BMI/(kg·m-2) 26.56±4.76 23.93±4.09 20.848 0.001 中心性肥胖 Central obesity 1 319(39.9) 897(37.2) 762.830 0.001 高血压 Hypertension 988(29.9) 900(37.2) 34.877 0.001 吸烟 Smoking 642(19.4) 487(20.2) 0.530 0.467 饮酒 Drinking 228(6.9) 199(8.3) 3.709 0.054 冠心病 Coronary heart disease 183(5.5) 56(2.3) 35.942 0.001 慢性胆囊炎 Chronic gallbladder disease 82(2.5) 97(4.0) 10.934 0.001 慢性肾脏病 Chronic kidney disease 99(3.0) 36(0.5) 13.639 0.001 高尿酸血症 Hyperuricemia 193(5.8) 104(4.3) 6.586 0.010 TG/(mmol·L-1)② 602(18.2) 203(8.4) 749.472 0.001 TC/(mmol·L-1)② 267(8.1) 99(4.1) 36.695 0.001 LDL-C/(mmol·L-1)② 189(5.7) 35(1.5) 67.396 0.001 HDL-C/(mmol·L-1)② 349(10.6) 385(16.0) 9.082 0.003 ALT/(IU·L-1)② 598(18.1) 75(3.1) 301.237 0.001 AST/(IU·L-1)② 256(7.7) 424(17.6) 128.832 0.001 ALP/(IU·L-1)② 581(17.6) 426(17.7) 0.008 0.928 GGT/(IU·L-1)② 326(9.9) 123(5.1) 43.665 0.001 GFR/(mL·min-1·1.73m-2)② 42(1.3) 26(1.1) 0.438 0.508 注:T2DM, 2型糖尿病; TG,三酰甘油;TC,总胆固醇;LDL-C,低密度脂蛋白胆固醇;HDL-C,高密度脂蛋白胆固醇;ALT,丙氨酸氨基转移酶;AST,门冬氨酸氨基转移酶;ALP,碱性磷酸酶;GGT,血清γ-谷氨酰转肽酶;GFR,肾小球滤过率。
①以人数(占比/%)或x±s表示;②为该指标异常人数的占比。
Note: T2DM, type 2 diabetes mellitus; TG, triglyceride; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; ALT, alanine aminotransferase; AST, aspartate transaminase; ALP, alkaline phosphatase; GGT, γ-glutamyl transferase; GFR, glomerular filtration rate.
① Number of people(proportion/%) or x±s; ② The proportion of people who are abnormal in this indicator.表 2 两民族按年龄、性别分层的2型糖尿病发病率
Table 2. The incidence of type 2 diabetes mellitus stratified by age and gender in both ethnic groups
年龄/岁
Age/years维吾尔族 Uyghurs① 哈萨克族 Kazak① 男性 Male 女性 Female χ2值 value P值 value 男性 Male 女性 Female χ2值 value P值 value 18~ < 35 532(5.6) 756(5.0) 0.234 0.628 307(4.2) 480(3.8) 0.116 0.773 35~ < 45 393(12.5) 488(8.0) 4.852 0.028 232(6.5) 367(4.6) 0.945 0.331 45~ < 55 259(23.6) 335(20.6) 0.746 0.388 202(13.9) 286(7.0) 6.297 0.012 55~ < 65 158(21.5) 209(31.1) 4.193 0.041 120(11.7) 173(9.8) 0.254 0.615 ≥65 94(26.6) 80(22.5) 0.390 0.532 124(11.3) 119(7.6) 0.984 0.321 合计 Total 1 436(13.9) 1 868(12.3) 1.841 0.175 985(8.5) 1 425(5.7) 6.906 0.009 χ趋势2 71.673 143.459 12.113 9.217 22.929 P趋势 0.001 0.001 0.001 0.002 0.001 注:①以人数(占比/%)表示。
Note: ① Number of people(proportion/%). -
[1] Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation [J]. Diabet Med, 1998, 15(7): 539-553. DOI: 10.1002/(SICI)1096-9136(199807)15:7<539:AID-DIA668>3.0.CO;2-S. [2] 马丽媛, 王增武, 樊静, 等. 《中国心血管健康与疾病报告2022》要点解读[J]. 中国全科医学, 2023, 26(32): 3975-3994. DOI: 10.12114/j.issn.1007-9572.2023.0408.Ma LY, Wang ZW, Fan J, et al. Interpretation of report on cardiovascular health and diseases in China 2022 [J]. Chin Gen Pract, 2023, 26(32): 3975-3994. DOI: 10.12114/j.issn.1007-9572.2023.0408. [3] 庄建文, 朱熠, 潘颖颖, 等. 新疆生产建设兵团居民慢性病流行病学调查分析[J]. 兵团医学, 2021, 19(4): 44-46. DOI: 10.3969/j.issn.1672-4356.2021.04.023.Zhuang JW, Zhu Y, Pan YY, et al. Epidemiological investigation and analysis of chronic diseases among residents of Xinjiang production and construction corps [J]. J Bingtuan Med, 2021, 19(4): 44-46. DOI: 10.3969/j.issn.1672-4356.2021.04.023. [4] Xu R, Zheng TJ, Ouyang CQ, et al. Causal associations between site-specific cancer and diabetes risk: a two-sample Mendelian randomization study [J]. Front Endocrinol, 2023, 14: 1110523. DOI: 10.3389/fendo.2023.1110523. [5] Chen JD, Cao SH, Jin Y, et al. Construction and validation of a nomogram of risk factors for new-onset atrial fibrillation in advanced lung cancer patients after non-surgical therapy [J]. Front Oncol, 2023, 13: 1125592. DOI: 10.3389/fonc.2023.1125592. [6] Sun K, Ren M, Liu D, et al. Alcohol consumption and risk of metabolic syndrome: a meta-analysis of prospective studies [J]. Clin Nutr, 2014, 33(4): 596-602. DOI: 10.1016/j.clnu.2013.10.003. [7] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版) [J]. 中华糖尿病杂志, 2021, 13(4): 95. DOI: 10.3760/cma.j.cn115791-20210221-00095.Chinese Society of Diabetes. Guidelines for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition) [J]. Chin J Diabetes, 2021, 13(4): 95. DOI: 10.3760/cma.j.cn115791-20210221-00095. [8] 中国成人血脂异常防治指南修订联合委员会. 中国成人血脂异常防治指南(2016年修订版) [J]. 中国循环杂志, 2016, 31(10): 937-950. DOI: 10.3969/j.issn.1000-3614.2016.10.001.Joint Committee on Revision of Chinese Guidelines for Prevention and Treatment of Adult Dyslipidemia. Guidelines for prevention and treatment of dyslipidemia in adults in China (revised in 2016) [J]. Chin Circ J, 2016, 31(10): 937-950. DOI: 10.3969/j.issn.1000-3614.2016.10.001. [9] World Health Organization. MONICA project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators [J]. J Clin Epidemiol, 1988, 41(2): 105-114. DOI: 10.1016/0895-4356(88)90084-4. [10] Levey AS, Coresh J, Balk E, et al. National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification [J]. Ann Intern Med, 2003, 139(2): 137-147. DOI: 10.7326/0003-4819-139-2-200307150-00013. [11] 徐培兰, 木日扎提·买买提, 孜克娅·乃吉木, 等. 新疆居民慢性病疾病谱现况调查及对策研究[J]. 卫生软科学, 2021, 35(2): 73-76. DOI: 10.3969/j.issn.1003-2800.2021.02.018.Xu PL, Murizhati MMT, Zikeya NJM, et al. Investigation on status quo of chronic disease spectrum of residentsin Xinjiang and its countermeasures [J]. Soft Science of Health, 2021, 35(2): 73-76. DOI: 10.3969/j.issn.1003-2800.2021.02.018. [12] 刘少博. 10省市队列人群糖尿病前期与糖尿病发病状况及影响因素研究[D]. 北京: 中国疾病预防控制中心, 2020.Liu SB. Study on the incidence of prediabetes and diabetes and related factors based on a cohort population from 10 provinces in China [D]. Beijing: Chinese Center for Disease Control and Prevention, 2020. [13] 汪慧, 薛振香, 利耀辉, 等. 新疆喀什地区维吾尔族成年居民糖尿病发病风险及影响因素[J]. 热带医学杂志, 2019, 19(10): 1288-1291. DOI: 10.3969/j.issn.1672-3619.2019.10.025.Wang H, Xue ZX, Li YH, et al. Ineidence and associated risk factors of diabetes mellitus among Uygur adult residents in Kashgar of South Xinjiang [J]. J Trop Med, 2019, 19(10): 1288-1291. DOI: 10.3969/j.issn.1672-3619.2019.10.025. [14] Bjørnholt JV, Erikssen G, Liestøl K, et al. Type 2 diabetes and maternal family history: an impact beyond slow glucose removal rate and fasting hyperglycemia in low-risk individuals? Results from 22.5 years of follow-up of healthy nondiabetic men [J]. Diabetes Care, 2000, 23(9): 1255-1259. DOI: 10.2337/diacare.23.9.1255. [15] Murakami T, Inagaki N, Kondoh H. Cellular senescence in diabetes mellitus: distinct senotherapeutic strategies for adipose tissue and pancreatic β cells [J]. Front Endocrinol, 2022, 13: 869414. DOI: 10.3389/fendo.2022.869414. [16] Bhatt PP, Sheth MS. Comparison of fatigue and functional status in elderly type 2 diabetes patients versus age and gender matched individuals [J]. Aging Med (Milton), 2024, 7(1): 84-89. DOI: 10.1002/agm2.12289. [17] 李亚丽. 金昌队列人群糖尿病前瞻性研究及多重巢式病例对照研究[D]. 兰州: 兰州大学, 2018.Li YL. Prospective study on diabetes mellitus in Jinchang cohort and multi-nested case-control study [D]. Lanzhou: Lanzhou University, 2018. [18] Klein S, Gastaldelli A, Yki-Jrvinen H, et al. Why does obesity cause diabetes? [J]. Cell Metab, 2022, 34(1): 11-20. DOI: 10.1016/j.cmet.2021.12.012. [19] Perdomo CM, Cohen RV, Sumithran P, et al. Contemporary medical, device, and surgical therapies for obesity in adults [J]. Lancet, 2023, 401(10382): 1116-1130. DOI: 10.1016/S0140-6736(22)02403-5. [20] 付朝伟. 农村社区成人2型糖尿病(德清队列)研究[D]. 上海: 复旦大学, 2010.Fu CW. Study on adult type 2 diabetes in rural community (Deqing cohort) [D]. Shanghai: Fudan University, 2010. [21] Bourke E, Maddison R, Blakely T. Getting the epidemiological associations of physical inactivity with diseases and injuries correct in comparative risk assessment [J]. Int J Epidemiol, 2023, 52(6): 1677-1680. DOI: 10.1093/ije/dyad107. [22] Wang Y, Gao J, Zhang L, et al. Bioinformatics analysis of lncRNA-related ceRNA networks in the peripheral blood lymphocytes of Kazakh patients with essential hypertension in Xinjiang [J]. Front Cardiovasc Med, 2023, 10: 1155767. DOI: 10.3389/fcvm.2023.1155767. [23] Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus [J]. World J Diabetes, 2015, 6(3): 456-480. DOI: 10.4239/wjd.v6.i3.456.